Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Chupin J"'
Autor:
Chupin, J, Nagano, A, Haley, V, Lenihan, C, Cavicchioli, F, O’Leary, K, Sahgal, N, Nigro, C, Shia, A, Chelala, C, Schmid, P
HER2 is over-expressed in around 20-25% of breast cancers. Due to increased cell growth and differentiation signaling resulting from HER2 over-expression, this sub-type of the disease is associated with aggressive tumor progression and poor prognosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::7bdb0742488438761515a6bc40fb3d19
https://ora.ox.ac.uk/objects/uuid:83337bf5-1a73-4802-8471-5350811a3023
https://ora.ox.ac.uk/objects/uuid:83337bf5-1a73-4802-8471-5350811a3023
Autor:
Min, B., Wietler, T., Bordihn, S., Peibst, R., Desrues, T., Carroy, P., Jourdan, J., Hermle, M., Feldmann, F., Bartsch, J., Allebée, C., Ding, L., Horzel, J., Lachowicz, A., Diaz Leon, J.J., Ingenito, A., Haug, F.-J., Schneiderlöchner, E., Linss, V., Köhler, R., Lüdemann, K., Campa, A., Bokalic, M., Topic, M., Zwegers, M., Hartlin, B., Field, B., Bénédicte, B., Richter, A., Adam, Z., Penaud, J., Filonovich, S., Harder, N., Marcon, E., Chupin, J., Tamini, F.
35th European Photovoltaic Solar Energy Conference and Exhibition; 229-232
The DISC project addresses the development of key technologies for the next generation of high-performance photovoltaic solar cells and modules. Our approach is to fully
The DISC project addresses the development of key technologies for the next generation of high-performance photovoltaic solar cells and modules. Our approach is to fully
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e35c781172804ad0dfd919c7eddd849a
Publikováno v:
In Applied Catalysis A, General 2001 206(1):43-56
Publikováno v:
Journal of Animal Science; August 1995, Vol. 73 Issue: 8 p2249-2253, 5p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Applied Animal Behaviour Science; 1994, Vol. 39 Issue: 2 p115-115, 1p
Autor:
Kee CW; Chemistry Research Laboratory , University of Oxford , 12 Mansfield Road , Oxford OX1 3TA , U.K., Tack O; Chemistry Research Laboratory , University of Oxford , 12 Mansfield Road , Oxford OX1 3TA , U.K., Guibbal F; Chemistry Research Laboratory , University of Oxford , 12 Mansfield Road , Oxford OX1 3TA , U.K.; Radiobiology Research Institute, Department of Oncology , University of Oxford , Headington, Oxford OX3 7LJ , U.K., Wilson TC; Chemistry Research Laboratory , University of Oxford , 12 Mansfield Road , Oxford OX1 3TA , U.K., Isenegger PG; Chemistry Research Laboratory , University of Oxford , 12 Mansfield Road , Oxford OX1 3TA , U.K., Imiołek M; Chemistry Research Laboratory , University of Oxford , 12 Mansfield Road , Oxford OX1 3TA , U.K., Verhoog S; Chemistry Research Laboratory , University of Oxford , 12 Mansfield Road , Oxford OX1 3TA , U.K., Tilby M; Chemistry Research Laboratory , University of Oxford , 12 Mansfield Road , Oxford OX1 3TA , U.K., Boscutti G; Invicro Ltd , Du Cane Road , London W12 0NN , U.K., Ashworth S; Invicro Ltd , Du Cane Road , London W12 0NN , U.K., Chupin J; Invicro Ltd , Du Cane Road , London W12 0NN , U.K.; Centre for Molecular Oncology, Barts Cancer Institute , Queen Mary University of London , London EC1M 6BQ , U.K., Kashani R; Centre for Molecular Oncology, Barts Cancer Institute , Queen Mary University of London , London EC1M 6BQ , U.K., Poh AWJ; Chemistry Research Laboratory , University of Oxford , 12 Mansfield Road , Oxford OX1 3TA , U.K., Sosabowski JK; Centre for Molecular Oncology, Barts Cancer Institute , Queen Mary University of London , London EC1M 6BQ , U.K., Macholl S; Invicro Ltd , Du Cane Road , London W12 0NN , U.K.; Centre for Molecular Oncology, Barts Cancer Institute , Queen Mary University of London , London EC1M 6BQ , U.K., Plisson C; Invicro Ltd , Du Cane Road , London W12 0NN , U.K., Cornelissen B; Radiobiology Research Institute, Department of Oncology , University of Oxford , Headington, Oxford OX3 7LJ , U.K., Willis MC; Chemistry Research Laboratory , University of Oxford , 12 Mansfield Road , Oxford OX1 3TA , U.K., Passchier J; Invicro Ltd , Du Cane Road , London W12 0NN , U.K., Davis BG; Chemistry Research Laboratory , University of Oxford , 12 Mansfield Road , Oxford OX1 3TA , U.K., Gouverneur V; Chemistry Research Laboratory , University of Oxford , 12 Mansfield Road , Oxford OX1 3TA , U.K.
Publikováno v:
Journal of the American Chemical Society [J Am Chem Soc] 2020 Jan 22; Vol. 142 (3), pp. 1180-1185. Date of Electronic Publication: 2020 Jan 13.
Autor:
Fearon AE; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Carter EP; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Clayton NS; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Wilkes EH; Integrative Cell Signalling and Proteomics, Centre for Haemato-Oncology, Barts Cancer Institute, London EC1M 6BQ, UK., Baker AM; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Kapitonova E; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Bakhouche BA; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Tanner Y; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Wang J; Centre for Molecular Oncology, Barts Cancer Institute, London EC1M 6BQ, UK., Gadaleta E; Centre for Molecular Oncology, Barts Cancer Institute, London EC1M 6BQ, UK., Chelala C; Centre for Molecular Oncology, Barts Cancer Institute, London EC1M 6BQ, UK., Moore KM; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Marshall JF; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Chupin J; Centre for Experimental Cancer Medicine, Barts Cancer Institute, London EC1M 6BQ, UK., Schmid P; Centre for Experimental Cancer Medicine, Barts Cancer Institute, London EC1M 6BQ, UK., Jones JL; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK., Lockley M; Centre for Molecular Oncology, Barts Cancer Institute, London EC1M 6BQ, UK., Cutillas PR; Integrative Cell Signalling and Proteomics, Centre for Haemato-Oncology, Barts Cancer Institute, London EC1M 6BQ, UK., Grose RP; Centre for Tumour Biology, Barts Cancer Institute-a CRUK Centre of Excellence, Queen Mary University of London, London EC1M 6BQ, UK. Electronic address: r.p.grose@qmul.ac.uk.
Publikováno v:
Cell reports [Cell Rep] 2018 Feb 27; Vol. 22 (9), pp. 2469-2481.